Dr. Scagliotti on the Future of Multiple Gene Profiles

Video

Dr. Giorgio Scagliotti from the University of Turin Discusses the Future of Multiple Gene Profiles

Giorgio V. Scagliotti, MD, PhD, head of the Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, believes that in the near future it will be possible to systematically investigate multiple genes to establish the full role of a pathway in the tumor.

The DNA repair protein ERCC1 is being describes as a paradigm for the entire DNA repair process, Scagliotti explains, however, that a single gene is not ample to mirror the entire DNA repair mechanism. Examining the full profile of several genes will provide better information about how to treat the patients properly and their cytotoxic profiles.

Related Videos
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center